Revenue Dynamics YoY (Last Twelve Months): Biora Therapeutics, Inc (BIOR)

Public company logo of Biora Therapeutics, Inc (BIOR)

Biora Therapeutics develops smart capsules for targeted drug delivery to replace injections, and the GURU.Markets portal provides this chart, where the year-over-year revenue trend for the last 12 months currently stands at -96.70. The company's innovative developments combine electronics and pharmacology to combat intestinal diseases. Currently, Biora Therapeutics (BIOR) is developing a line of drugs against colitis, which are currently undergoing clinical trials.

BIOR Biora Therapeutics Inc.: Revenue Growth YoY (Last 12 Months) in the range 02/11/2024 - 02/20/2024

Biora Therapeutics, Inc. (BIOR) - metric breakdowns and financial figures

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:Biora Therapeutics
Product sample of bioratherapeutics.com

This indicator calculates the daily difference in revenue over a rolling year, allowing for an assessment of the real business expansion dynamics and management effectiveness for Biora Therapeutics (BIOR). By analyzing the trajectory of annual revenue changes over 12 months, an investor can determine whether the uniqueness of the NaviCap technology and the inelastic demand for targeted antibody delivery are converting into stable financial growth or capital stagnation.